It was found that higher levels of CX3CL1-CX3CR1 and plasma soluble CX3CL1 in patients with pulmonary hypertension than in the control group and the expression and function of CX3CL1 in circulating T cells were upregulated [28]. This evidence concerns the gene CX3CL1 and pulmonary arterial hypertension.